ArticleAdvanced biomedical research2025
Investigating the Effect of Coenzyme Q10 Supplementation on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Chemotherapy: A Randomized Clinical Trial.
Article in Advanced biomedical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coenzyme Q10 (CoQ10) is a powerful antioxidant and the main cause of kidney problems caused by cisplatin consumption is due to the low power of antioxidants. This study aimed to evaluate the effect of CoQ10 supplementation on cisplatin-induced nephrotoxicity in patients undergoing chemotherapy as a double-blind clinical trial. Materials and Methods: In this randomized clinical trial, cancer patients referred to the educational hospital of Shahrekord were divided randomly into two groups. The patients received ubiquinone 300 mg daily during the 8 weeks. Fasting blood samples were collected for testing before and after intervention. Data were analyzed by SPSS software version 21 (SPSS Inc., Chicago, IL, USA) using descriptive and analytic tests. Results: The mean of blood urea nitrogen (BUN), blood creatinine (Cr), and glomerular filtration rate (GFR) did not show a significant difference between the two groups before and after the intervention. The mean difference within the Cr group showed the mean stages before and after the intervention increased significantly and the GFR had a significant decrease ( Conclusion: The mean of BUN, blood creatinine, and GFR were not different between the two groups, before and after the intervention. The average creatinine levels increased after intervention between the mean of pre-intervention and post-intervention stages increased and GFR decreased; however, in the case of BUN, the opposite was not the case. This study's results can be used as a guide in drug administration for patients undergoing chemotherapy to reduce the renal side effects of prescribed drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.